{
    "2021-08-24": [
        [
            {
                "time": "2021-08-23",
                "original_text": "Johnson & Johnson (JNJ) Stock Sinks As Market Gains: What You Should Know",
                "features": {
                    "keywords": [
                        "JNJ",
                        "Stock Sinks",
                        "Market Gains"
                    ],
                    "sentiment_score": -0.6,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-09-01",
                "original_text": "Ovarian Cancer Victims Ask Court to Block Johnson & Johnson's 'Texas Two-Step' Bankruptcy Plan",
                "features": {
                    "keywords": [
                        "Ovarian Cancer",
                        "Court",
                        "Bankruptcy Plan"
                    ],
                    "sentiment_score": -0.7,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "legal"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "none"
                }
            },
            {
                "time": "2021-08-25",
                "original_text": "Unvaccinated LA residents were 29 times more likely to be hospitalized with COVID-19: CDC study",
                "features": {
                    "keywords": [
                        "Unvaccinated",
                        "LA residents",
                        "COVID-19",
                        "CDC study"
                    ],
                    "sentiment_score": -0.4,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health"
                    ],
                    "causal_factor": "false",
                    "causal_impact": "none",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-24",
                "original_text": "Theravance Stock Crashes; Can Longer Testing Salvage Its J&J-Partnered Drug?",
                "features": {
                    "keywords": [
                        "Theravance",
                        "Stock Crashes",
                        "J&J-Partnered Drug"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-08-27",
                "original_text": "Is JNJ Stock A Buy As Covid Vaccine Recipients Await News On Boosters?",
                "features": {
                    "keywords": [
                        "JNJ Stock",
                        "Covid Vaccine",
                        "Boosters"
                    ],
                    "sentiment_score": 0.5,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "biotech"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-26",
                "original_text": "3 COVID Vaccine Makers to Watch on Pfizer Jab Full FDA Approval",
                "features": {
                    "keywords": [
                        "COVID Vaccine",
                        "Pfizer",
                        "FDA Approval"
                    ],
                    "sentiment_score": 0.7,
                    "policy_related": "true",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-08-28",
                "original_text": "UPDATE 1-With full vaccine approval, U.S. could control COVID by spring 2022 -Fauci",
                "features": {
                    "keywords": [
                        "full vaccine approval",
                        "U.S.",
                        "control COVID",
                        "Fauci"
                    ],
                    "sentiment_score": 0.6,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "public health"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2021-09-02",
                "original_text": "Theravance Stock Plunges As JAK Inhibitor Flops Ulcerative Colitis Study",
                "features": {
                    "keywords": [
                        "Theravance",
                        "Stock Plunges",
                        "JAK Inhibitor",
                        "Ulcerative Colitis"
                    ],
                    "sentiment_score": -0.8,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "healthcare",
                        "pharmaceuticals"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2021-09-03",
                "original_text": "UPDATE 1-Six U.S. states do not join $26 bln opioid settlements with distributors, J&J",
                "features": {
                    "keywords": [
                        "U.S. states",
                        "opioid settlements",
                        "distributors",
                        "J&J"
                    ],
                    "sentiment_score": -0.5,
                    "policy_related": "true",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "healthcare",
                        "legal"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            }
        ]
    ]
}